Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07140770 · ClinicalTrials.gov registry record

Sleep and Physical Activity in Patient and Caregiver Dyads Following Allogeneic Hematopoietic Cell Transplantation

A clinical trial of Sleep and Physical Activity, sponsored by M.D. Anderson Cancer Center.

Recruiting
Registry status
66
Enrollment target
1
Study location

NCT07140770 is a study of Sleep and Physical Activity that is actively recruiting participants, run by M.D. Anderson Cancer Center. The registered enrollment target is 66 participants, below the 4,166-participant average among 151 other Sleep trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07140770, a study of Sleep and Physical Activity, is actively recruiting participants, sponsored by M.D. Anderson Cancer Center.

RECRUITING
Registry status
66 participants
Enrollment target
1
Study location

Study Summary

To understand the changes in health-related quality of life of patients and caregivers after allogeneic hematopoietic cell transplantation.

Interventions

  • OTHER Questionnaire
  • DEVICE Fitbit

Study Locations (1)

Texas

  • MD Anderson Cancer Center - Houston

Trial Details

FieldValue
Enrollment Target 66 participants
Start Date 2025-09-02
Est. Completion 2028-04-01

Sponsor

M.D. Anderson Cancer Center

2,692 total trials

What the Registry Record Tells You About NCT07140770

The ClinicalTrials.gov registry entry for NCT07140770 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 66 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,166-participant average among 151 other Sleep trials with a reported enrollment target (98% lower). The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Sleep appearing as the primary indexed condition, and to 2 interventions - of which Questionnaire is the first listed.

NCT07140770 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT07140770 about?

NCT07140770 is a clinical study titled "Sleep and Physical Activity in Patient and Caregiver Dyads Following Allogeneic Hematopoietic Cell Transplantation". To understand the changes in health-related quality of life of patients and caregivers after allogeneic hematopoietic cell transplantation.

What is the current status of trial NCT07140770?

This trial is currently recruiting. The enrollment target is 66 participants. The study started on 2025-09-02. Estimated completion is 2028-04-01.

What conditions does trial NCT07140770 study?

This clinical trial studies the following conditions: Sleep, Physical Activity, Allogenic Hematopoietic Cell Transplant.

What interventions are being tested in trial NCT07140770?

The interventions under investigation include: Questionnaire (OTHER), Fitbit (DEVICE).

Who is sponsoring clinical trial NCT07140770?

This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07140770 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Sleep

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.